Li, Hongjian
Name
Li, Hongjian
Loading...
4
0
5
0
false
Results 1-3 of 3
Issue Date | Title | Author(s) | Type | |
---|---|---|---|---|
1 | 2017 | In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma | Ke, Kunbin ; Li, Hongjian ; Yao, Hong ; Shi, Xi-Nan ; Dong, Chao ; Zhu, Ying ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Wong, Man-Hon ; Liu, Xiao-Dong ; Kung, Hsiang-fu ; Lin, Marie Chia-mi | Peer Reviewed Journal Article |
2 | 2015 | In silico identification and in vitro and in vivo validation of anti-psychotic drug fluspirilene as a potential CDK2 inhibitor and a candidate anti-cancer drug | Shi, Xi-Nan ; Li, Hongjian ; Yao, Hong ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Kung, Hsiangfu ; Lu, Di ; Wong, Man-Hon ; Lin, Marie Chia-Mi | Peer Reviewed Journal Article |
3 | 2015 | Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma | Shi, Xi‑Nan ; Li, Hongjian ; Yao, Hong ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Kung, Hsiang‑Fu ; Lin, Marie Chia‑Mi | Peer Reviewed Journal Article |